VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filings

SEC Filings

Filing date Form Description Filing Group View
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

Other
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
8-A12B

Registration of certain classes of securities 12(b) of the Securities Exchange Act

Registration Statements
View HTML

Data provided by Kaleidoscope.

Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |